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Abstract (227 words) 
Background. Whether and to what degree psychotherapy leads to changes in patients’ value-
based actions is not well documented. In this study we examined whether cognitive 
behavioral therapy, without explicit values work, enhanced value-oriented action. We also 
explored the role of change in valued action for subsequent life satisfaction and continued 
change after therapy. Additionally, data on the reliability and validity of the Valued Living 
Questionnaire (VLQ) are reported. 
Methods. We analyzed the pre-, post-, and 6-month-follow-up-data of 3,687 patients of a 
university psychotherapy outpatient clinic, most of which suffered from reliably diagnosed 
anxiety and mood disorders. Questionnaires included the VLQ (with 10 items each on the 
"importance" and "consistency" of values), symptom scales (Beck Depression Inventory; 
Brief Symptom Inventory), and the Satisfaction with Life Scale. 
Results. Over the course of therapy significant improvements in value-oriented action were 
found (d = .34), especially in treatment responders (d = .51). Increase of value-oriented action 
significantly explained satisfaction with life at end of treatment, even after controlling for 
symptom reduction. Temporally preceding improvement on the VLQ predicted further 
symptom reduction until follow-up.  
Conclusion. Data indicate that psychotherapy positively affects valued living, even when it is 
not explicitly targeted in treatment. Valued living may have a role in the course and 
maintenance of therapeutic change.  
 
Keywords: Valued Living Questionnaire – valued action – psychometric properties – 
treatment satisfaction – positive side effects
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Introduction 
Personal values are abstract desirable goals that serve as guiding principles in 
peoples’ lives (Kluckhohn, 1951). As such, they transcend specific circumstances and are 
important over time (Roccas & Sagiv, 2010). Similarly, values have also been defined as 
“personal choices about what is important in life, which can guide the selection of behaviors 
and lead to satisfaction even in the absence of external reinforcement” (Berghoff, Forsyth, 
Ritzert, Eifert & Anderson, p.1388).  This definition makes clear that taking actions that are 
closely connected to personal values might be of central importance for psychological 
functioning (see, e.g., Vowles,McCracken, &O'Brien, 2011) and well-being (Welzel & 
Inglehart, 2010), a finding that makes the concept of values relevant also for clinical 
psychology and psychotherapy. 
The role of values and of the degree to which people personally feel capable of living 
up to them has recently been particularly emphasized by proponents of Acceptance and 
Commitment Therapy (ACT; Hayes, Strosahl & Wilson, 2012). . Several therapeutic 
interventions aiming at the clarification of values and at a better commitment to one’s values 
have been proposed in ACT. Furthermore, ACT theory formulates assumptions about the role 
that the “activation of values” plays for human change in general. Most importantly, it has 
been postulated that changes in valued living can precede further changes, e.g., in symptom 
reduction (Gloster, Klotsche, et al., 2017). Apart from some recent exceptions (S. A. Hayes, 
Orsillo, & Roemer, 2010; Wersebe et al., 2017), empirical data on change in valued living are 
rare, despite their potential to contribute to a better understanding of general therapeutic 
change processes. 
One open question is to what extent increased valued living is a typical characteristic 
of any successful psychotherapy and not only of successful ACT as shown by Hayes et al. 
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(2010) or Wersebe et al. (2017). A promotion of valued living is, for example, not explicitly 
intended within Cognitive Behavioral Therapy (CBT), which primarily aims at the reduction 
of clients’ suffering by reducing the symptomatic behavior (see e.g. Craske, 2010; Gloster et 
al., 2017). Nevertheless, it can be argued that psychotherapeutic treatment (like CBT)  
impacts more than isolated symptoms as conceptualized by the classical medical model or 
other mechanistic explanations of human behavior (Hoyer, 2016). Psychotherapy can rather 
be assumed to affect patients’ personal vulnerabilities and risk-factors (such as low self-
esteem or low self-efficacy) in a generalized way and the corresponding changes might have  
broad impact on a person’s psychological life situation. . In the case of CBT it can be 
assumed that it helps to reduce behavioral and experiential avoidance, teaches skills and 
competencies to solve problems and broadens the overall capacity to behave adaptively under 
stress (see, e.g., Craske, 2010).  All these improvements can be expected to reduce the 
psychological barriers for the individual to more fully engage in their personally relevant 
values. Following this logic, we expected an increase in valued living to occur during or after 
successful psychotherapeutic treatment with CBT, even if no explicit strategies to clarify 
values or to enhance valued action (as in ACT) had been applied. Such an unspecific effect of 
psychotherapy (here: CBT) on valued living has, to our knowledge, not been previously 
tested.  
Our second research question asks how important the increase in valued living is for 
the life satisfaction of psychotherapy patients.  
 Reflecting on claims that both positive mental health and psychopathology should be 
monitored in psychotherapy research (Cougle, 2012; Hoyer, 2016; Keyes, 2005; Trompetter, 
Lamers, , Westerhof, Fledderus & Bohlmeijer, 2017)., we were interested in analyzing 
whether progress in symptom reduction and increase in valued living  independently leads to 
enhanced satisfaction with life after psychotherapy. Since valued living as a concept is clearly 
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distinguishable from symptoms and symptom reduction, it should independently contribute to 
the explanation of satisfaction with life after therapy if it is indeed important. More precisely, 
our second hypothesis postulates that increased valued living explains satisfaction with life 
after therapy even when the effects of symptom reduction are statistically controlled.  
Our third research question was aimed at investigating whether improved valued 
living precedes symptom reduction. Typically, as posited in the so called consequence model, 
clinicians expect that changes in suffering precede changes in the other variables, e.g., in 
values, a process that was called remoralization, e.g., by Howard, Lueger, Maling, & 
Martinovich, (1993). This position is contrasted by the antecedence model (equivalent to 
ACT theory; cf. S. C. Hayes et al., 1999) which posits that changes in experiential acceptance 
and valued action can temporally precede changes in suffering. Given that we could measure 
change in our study between treatment start (baseline, BL), treatment end (post-treatment, 
Post), and at 6-month follow-up (FU), a test of the antecedence model would implicate that 
changes of valued action between BL and Post precede change in suffering (as measured via 
symptom variables) that occurs only between Post and FU. This was our third hypothesis. 
Summarizing, three assumptions about valued action and its function in 
psychotherapy, namely CBT, were tested: We assumed that valued living increases during 
CBT (Hypothesis 1), that these changes predict the satisfaction with life after therapy over 
and above the effects due to reduction of symptoms (Hypothesis 2), and that these changes 
predict subsequent changes in suffering that occur between end of treatment and follow-up 
(Hypothesis 3). 
The strength of our tests, its internal validity, largely depends on the reliability and 
validity of the measures used. While we could use well-validated self-report measures for 
general psychopathology, depression, and satisfaction with life (see below), the reliability and 
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validity of the measure for valued living, the Valued Living Questionnaire (VLQ; Wilson et 
al., 2010), has been studied less frequently in research contexts outside of ACT studies. 
Therefore, we will also report on the internal consistency and selected aspects of construct 
validity of VLQ. 
Methods 
Study design and sample 
We analyzed the BL, Post, as well as FU data of N = 3,687 patients of a university 
psychotherapy outpatient clinic collected between February 2004 and February 2015. All 
patients gave their written consent and were reliably diagnosed using the DSM-IV Munich-
Composite International Diagnostic Interview (M-CIDI; Wittchen & Pfister, 1997). The time 
between BL and Post differed depending on the course of therapy. The average duration of 
treatment was M = 26.23 sessions (SD = 18.27) and M = 267 days (SD = 274.43). The FU 
took place six months after treatment completion. As we collected data from an outpatient 
clinic, and not within a controlled study, only 19.7% of the original sample (n = 727) 
completed the FU assessment. If FU was not returned by the patients as requested, no further 
measures to contact the patient were taken. The sociodemographic and clinical characteristics 
of the sample are shown in Table 1. 
Measures 
At BL, Post and FU participants were asked to complete the VLQ, the Beck 
Depression Inventory II (BDI-II, Beck, Steer, & Brown, 1996; German Version: Hautzinger, 
Keller, & Kühner, 2006), the Brief Symptom Inventory (BSI; Derogatis, 1993; German 
Version: Geisheim et al., 2002), and the Satisfaction with Life Scale (SWLS; Diener, 
Emmons, Larsen, & Griffin, 1985; German Version: Glaesmer, Grande, Braehler, & Roth, 
2011). In the present study, the German versions of the instruments were used. 
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VLQ. The VLQ focuses on ten central domains of human activity, namely: family, 
marriage/couple/intimate relationships, parenting, friendship, work, education, recreation, 
spirituality, community life, and physical wellbeing. On a scale from 1-10 (in the German 
version, on scale from 1-5) patients estimate how important these domains are for them and 
how consistently they pursue goals within these domains. This makes it possible to assess 
inconsistencies between importance and effort. From these scales, we calculated an average 
score for Importance (V-I) and Valued Action (V-A, i.e. consistency scale) across the 
domains. Also, a Valued Living Composite (VLQ-C) for each domain was calculated by 
multiplying its respective importance and consistency score. Preliminary studies (Wilson et 
al., 2010) showed good internal consistency for the V-I scale (α = .79-.83) and adequate 
internal consistency for the V-A scale (α = .58-.60) and the VLQ-C (α = .65-.74). However, 
since psychometric properties of the German version of the VLQ are lacking, we calculated 
them in the present study. 
BDI-II. The BDI-II consists of 21 items. The items are rated on a four-point scale (0-
3) and depict cognitive (e.g. self-dislike, pessimism, guilt) and somatic-affective dimensions 
(e.g. loss of energy, changes in appetite, fatigue) of depression (Steer, Ball, Ranieri, & Beck, 
1999). The total score can range from 0-63. The BDI-II showed high internal consistency (α 
= .92-.93) and high test-retest reliability (r = .93; Beck et al., 1996). 
BSI. The BSI is a short version of the symptom checklist SCL-90-R (Derogatis, 
1977). It consists of 53 items that cover clinically relevant symptoms across nine dimensions: 
somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, 
phobic anxiety, paranoid ideation, and psychoticism. Four of the 53 items do not load on any 
dimension, but are included because of their clinical relevance (Derogatis, 1993). The items 
are rated on a five-point scale, reflecting the severity of distress from 0 (not at all) to 4 
(extremely). The item scores can be summarized into three global indices. For the present 
8 
 
study, we used the Global Severity Index (GSI), which represents the mean of the completed 
item scores. The GSI is only calculated if there are not more than 13 missing values overall 
(and >1 per dimension; Franke, 2000). For the German version, Cronbach’s α-coefficients of 
the dimensions ranged from .70 to .89, while the GSI had an α of .96 (Geisheim et al., 2002). 
SWLS. The SWLS consists of five statements related to satisfaction with one’s life 
(Diener et al., 1985). The Items are assessed on a 7-point scale that indicate the degree of 
agreement with the statements, ranging from 1 (strongly disagree) to 7 (strongly agree). The 
items are summed into a total score that can range from 5-35. The SWLS showed high 
internal consistency (α = .87) and good test-retest reliability (r = .82) 
Statistical analyses 
The statistical analyses were conducted using Stata Statistical Software Version 14.2. 
(StataCorp, 2015). Changes between BL, Post and FU were calculated using linear regression 
analyses with time being dummy-coded and modeled as discrete (0 = BL, 1 = Post, 2 = FU). 
The effect sizes (ES) were derived as differences in means divided by the standard deviation 
at BL. In accordance with Cohen (1988), ES of 0.2 were interpreted as small, ES of 0.5 as 
medium and ES of 0.8 and bigger as large. This analysis was carried out for treatment 
responders as a sub-sample as well. Responders were patients that had a decrease of 47% in 
their BDI-II scores from BL to Post (Riedel et al., 2010). For Hypothesis 2 (H2) and 3 (H3), 
separate hierarchical regression analyses were conducted. For H2, SWLS at Post was used as 
outcome, while the BL scores of SWLS, GSI, BDI-II and VLQ-C were entered in the first 
step. In the second step the changes from BL to Post in BSI (ΔGSIBL-Post) and in BDI-II 
(ΔBDIBL-Post) were added as predictors, while in the third and final step the change in the 
VLQ Composite from BL to Post was entered (ΔVLQ-CBL-Post). For H3, the changes from 
Post to FU in GSI (ΔGSIPost-FU) and in BDI-II (ΔBDIPost-FU) were used as outcomes, while the 
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BL scores of BDI, GSI and VLQ-C were entered in the first step, and the ΔVLQ-CBL-Post in 
the second and final step. All predictors in the hierarchical regression analyses were centered 
at their means. In all analyses, the p-value was set to .05. 
Results 
Descriptive statistics 
Internal consistency of the VLQ. The scales had a comparatively low internal 
consistency, with α = .62 for V-I, α = .67 for V-A, and α = .66 for VLQ-C. This was to be 
expected as the scales depicted in the VLQ cannot fully be regarded as homogenous traits but 
needs to be considered when interpreting the correlational findings with the VLQ reported 
below. 
VLQ. At baseline most values were indicated as highly important (>4 points on the 1-
5 scale; see Figure 1). Only education/training, citizenship/community life and spirituality 
were considered less important (<4). The values with the highest V-A scores were 
friends/social life and family (both >3), while other values had a V-A scored below three. 
The largest discrepancies were found for physical self-care and marriage/couples/intimate 
relationships (1.72 and 1.60), followed by work and recreation/fun (both 1.30).  
We also analyzed in how many instances per patient there was a discrepancy between 
the importance of a value and its respective consistency at baseline. Only n = 13 (0.35%) 
patients had no discrepancies in any of the domains, while n = 28 (0.76%) had a discrepancy 
in only one life domain. A total of n = 73 (1.98%) patients had two discrepancies, n = 119 
(3.23%) had three discrepancies, n = 213 (5.78%) had four discrepancies, and n = 372 
(10.09%) had five discrepancies. A total of 77.81% of all patients (n = 2869) revealed 
discrepancies in more than five domains. The most frequent discrepancies were reported in 
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the domains of physical self-care, fun/recreation and work, while the least discrepancies 
occurred in the domains of spirituality and citizenship (see also Fig. 1). 
Means and standard deviations. The statistics of all measures at BL, Post and FU 
for the complete sample and for the subsample of responders are shown in Table 2. The 
differences and effect sizes from BL to Post and to FU are depicted in Table 3. 
Correlation analyses. There were medium to large correlations between the 
outcomes at BL. All correlations were significant (see Table 4). 
Hypothesis 1 
The scores of the VLQ showed significant increases from BL to Post and from BL to 
FU in the VLQ-C and V-A scores, as well as decreases in the V-I values. There were no 
differences from Post-FU. While the ES for V-I were small, the ES for V-A and VLQ-C were 
mostly moderate sized (Table 3). For the sub-sample of those showing clinically significant 
response with respect to their depressive symptoms, the ES were even stronger reaching 
medium size for V-A and VLQ-C (Table 3). In sum, Hypothesis 1 could be confirmed: CBT 
increases valued living. 
Hypothesis 2 
As the hierarchical regression analysis shows (see Table 5), increases in VLQ-C 
predict life satisfaction over and above the effects of mere symptom reduction. They 
explained an additional 3.74% of the variability in SWLS at end of treatment (as indicated by 
the ΔR2 in Block 3). The final model overall explained 62.9% of the variance. These results 
confirm Hypothesis 2.  
Hypothesis 3 
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As the results show, the changes in VLQ that have occurred during therapy did predict 
subsequent change from Post to FU in GSI, as well as BDI (see Table 6). This confirms our 
third hypothesis: Increases in valued living precede the reduction of symptoms.  
Discussion 
In this naturalistic study we observed that patients report an increase in valued living 
during CBT (confirming Hypothesis 1), that these changes predicted the satisfaction with life 
after therapy over and above the effects due to reduction of symptoms (confirming 
Hypothesis 2), and that these changes predicted subsequent changes in suffering that occur 
between end of treatment and follow-up (confirming Hypothesis 3). These findings contradict 
models of change that assume symptom reduction to be a prerequisite for improved life 
satisfaction of patients. They are rather consistent with the idea that also change in valued 
action has a role for subsequent life satisfaction and continued change after therapy.  
Furthermore, descriptive statistical analyses of the VLQ indicated that the items 
reflect domains that matter to people in that seven out of the 10 items included in the VLQ 
were rated as important (rated on average at least 4 on a five-point scale). At the same time, 
the VLQ demonstrated its potential to help clarify which values are consistently met or not as 
more than 99% of the respondents indicated to not live up fully to one or more values. This 
finding also signals that perfectly living up to the own values is an ideal which can usually 
not be met in life.   
Results further show that CBT helps to increase valued living - even assuming that no 
specific techniques were applied to provoke this effect. However, given that we could not 
conduct empirical adherence analyses of the therapeutic interventions used during session 
based expert ratings, we cannot rule out that some therapists might have used some kind of 
values work in their session as the concept of values has become more prominent in the past 
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years. Our findings can therefore only be interpreted as preliminary evidence for the 
assumption that indeed different types of psychotherapy have the potential to influence the 
amount of valued behavior a person realizes in life, no matter if this is an explicit aim of the 
therapy style (as is the case in ACT) or rather a “positive side effect” (Hoyer, 2016) of the 
therapeutic measures taken to systematically change approach and avoidance tendencies of 
patients. It is an interesting scientific question for the future to what extent ACT would 
outperform conventional CBT in direct comparison studies in terms of enhancement of 
valued living and which further consequences of these potential differences between the two 
therapeutic strategies will be observable in longitudinal investigations. 
ACT itself does not claim to outperform other therapeutic approaches in terms of 
symptom reduction and does not do so in conscientiously conducted RCTs (e.g. Arch et al., 
2012). ACT rather focuses on the reduction of struggling with given life circumstances. 
Following ACT logic, we argued that an increase in valued living would lead not only to 
symptom reduction (e.g., as valued action can include reduced avoidance), but also to 
heightened satisfaction with life. Although the symptom reduction did explain a relevant 
portion of the variance of satisfaction with life after therapy, increase of valued living 
independently explained additional variance. However, it has to be taken into account here 
that the treatment was not delivered in a short-term intense form but rather applied over 
longer time periods. This makes it possible that other more imminent life events might shape 
self-ratings of life satisfaction and that, in other words, therapeutic effects may only be 
among many others to explain satisfaction with life.  
According to the antecedence model underlying ACT, we hypothesized that gains in 
valued living precede subsequent symptom reduction. Would those who improved their 
valued living during therapy show more subsequent reduction of general psychopathological 
symptoms and depression in the follow-up period? There was indication for such an effect in 
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these data. This suggests that valued action has not only a buffer effect against further 
symptoms (and/or its relapse), but the engagement in valued living at one time has an 
advantageous effect on symptoms in the future. This is theoretically relevant because it runs 
counter to the implicit assumptions, teachings, and recommendations inherent in Western 
psychology, psychiatry, medicine, and even the self-help industry. Whereas reduction or 
elimination of uncomfortable symptoms is certainly desirable, their reduction or elimination 
is not a necessary condition for living life in a way that patients choose.  
A number of limitations need to be clarified. Starting with the psychometric properties 
of our measure of valued living, the VLQ has conceptual and psychometric limitations as 
previous articles have criticized (Gloster, Klotsche, et al., 2017; Smout, Davies, Burns, & 
Christie, 2014). While the measure has good face validity and clinical relevance, the internal 
consistency was unsatisfying in terms of classical test theory and the relatively low reliability 
coefficients might have led to underestimations of the correlation coefficients reported. 
Furthermore, our naturalistic study used data from just three different time points, giving us 
only a very rough basis for analyzing temporal patterns of change. In order to model the 
process of change more detailed it would be good to have studies acquiring data at much 
more time points. The temporal relations between valued living and symptom measures 
during the course of therapy should rather be analyzed on a session-to-session or, even better, 
on a moment-to-moment basis during the session. Another limitation is the number of initial 
patients that responded to our inquiries at follow-up, which could implicate a possible 
selection bias with reference to Hypothesis 3. This concern is mitigated somewhat in that 
comparisons between the complete sample and those that responded to follow up did not 
reveal different patterns at other time points. Finally, all our data were gained by self-report 
instruments. Thus, we do not have objective, external information whether there was a real, 
observable change in valued action. Further research might include more real-life information 
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in order to estimate the changes in the patients’ life more precisely (Gloster, Miché, et al., 
2017).  
Despite these limitations our data demonstrate that inclusion of valued living is one 
good example for broadening the scope of what constitutes a good outcome in psychotherapy 
(see Rønnestad et al., 2018). Furthermore, we see our study as an important support for the 
assumption that valued living changes in other therapies than ACT as well, and has further 
effects on other important life domains – an idea that is worth investigating in further studies. 
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Tables 
Table 1. Sociodemographic and clinical characteristics of the sample [Link back to sample] 
Characteristics Descriptives 
Age, M (SD) 35.28 (13.27) 
Female, % 65.69 
Years of education, %  
 8-10 48.34 
 11-13 45.20 
 14+ 6.46 
In relationship, yes % 62.47 
Primary diagnoses, %  
 F0 0.29 
 F1 5.22 
 F2 0.77 
 F3 34.74 
 F4 46.88 
 F5 8.84 
 F6 1.85 
 Other 0.49 
Number of diagnoses, %  
 2 30.04 
 3 18.57 
 4 9.32 
 5+ 7.09 
Note. F0 = Organic mental disorders; F1 = Disorders due to psychoactive substance use; F2 
= Schizophrenia, schizotypal and delusional disorders; F3 = Affective disorders; F4 = 
Anxiety, stress-related and somatoform disorders; F5 = Behavioral syndromes associated 
with physiological disturbances and physical factors; F6 = Disorders of adult personality 
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Table 2. VLQ, GSI, BDI and SWLS scores at Baseline, Post and FU in the complete sample (N = 3687) and responders only (n = 849) [Back to 
Results] 
Variables Complete sample Responders only 
 BL Post FU BL Post FU 
 M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) 
VLQ       
 V-I 3.95 (0.49) 3.92 (0.49) 3.90 (0.49) 4.02 (0.44) 3.95 (0.45) 3.94 (0.47) 
 V-A 2.86 (0.62) 3.12 (0.62) 3.19 (0.64) 2.89 (0.57) 3.26 (0.56) 3.31 (0.57) 
 VLQ-C 11.87 (3.14) 12.94 (3.25) 13.11 (3.31) 12.09 (2.88) 13.56 (2.99) 13.65 (3.02) 
GSI 1.08 (0.65) 0.52 (0.54) 0.51 (0.52) 1.05 (0.60) 0.32 (0.34) 0.37 (0.39) 
BDI-II 17.16 (10.40) 8.35 (8.56) 8.91 (9.17) 17.52 (9.44) 4.47 (5.07) 6.33 (6.92) 
SWLS 17.23 (6.99) 21.56 (7.00) 21.58 (7.25) 17.63 (6.88) 23.60 (5.98) 23.09 (6.63) 
Note. VLQ = Valued Living Questionnaire; V-I = Values Importance (Range 1-5); V-A = Valued Action (Range 1-5); VLQ-C = Valued Living 
Questionnaire Composite (Range 1-25); GSI = Global Severity Index (Range 0-4); BDI-II = Beck-Depression Inventory – II (Range 0-63); SWLS 
= Satisfaction with Life Scale (Range 0-25); BL = Baseline, Pre-treatment; Post = Post-treatment; FU = Follow-up 
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Table 3. Within-group differences and effect sizes in VLQ, GSI, BDI and SWLS for the 
complete sample and for responders [Back to Results]. 
Variables Differences 
Complete sample Responders only 
t p ES [95% CI] t p ES [95% CI] 
V-I BL-Post -2.80 <.01 -0.08 [-0.14, -0.02] -3.31 <.01 -0.16 [-0.26, -0.06] 
 BL-FU -3.26 <.01 -0.13 [-0.21, -0.05] -3.24 <.01 -0.19 [-0.31, -0.08] 
 Post-FU 0.96 =.34 0.04 [-0.05, 0.13] 0.51 =.61 0.03 [-0.08, 0.14] 
V-A BL-Post 13.57 <.01 0.42 [0.37, 0.49] 13.40 <.01 0.64 [0.55, 0.74] 
 BL-FU 13.04 <.01 0.53 [0.45, 0.61] 12.60 <.01 0.73 [0.62, 0.85] 
 Post-FU -2.23 =.02 -0.10 [-0.19, -0.01] -1.57 =.12 -0.09 [-0.21, 0.02] 
VLQ-C BL-Post 10.67 <.01 0.34 [0.28, 0.40] 10.31 <.01 0.51 [0.41, 0.61] 
 BL-FU 9.59 <.01 0.40 [0.31, 0.48] 9.03 <.01 0.54 [0.42, 0.66] 
 Post-FU -1.17 =.24 -0.05 [-0.15, 0.03] -0.53 =.59 -0.03 [-0.15, 0.08] 
GSI BL-Post -36.15 <.01 -0.85 [-0.90, -0.80] -40.64 <.01 -1.21 [-1.27, -1.15] 
 BL-FU -30.98 <.01 -0.87 [-0.93, -0.82] -32.89 <.01 -1.13 [-1.19, -1.06] 
 Post-FU 0.63 =.53 0.02 [-0.04, 0.08] -2.53 =.01 -0.08 [-0.15, -0.02] 
BDI BL-Post -70.82 <.01 -0.77 [-0.79, -0.75] -46.15 <.01 -1.38 [-1.44, -1.32] 
 BL-FU -76.98 <.01 -0.84 [-0.86, -0.82] -34.32 <.01 -1.18 [-1.25, -1.11] 
 Post-FU 6.15 <.01 0.07 [0.05, 0.09] -5.84 <.01 -0.20 [-0.26, -0.13] 
SWLS BL-Post 24.19 <.01 0.61 [0.57, 0.67] 23.79 <.01 0.63 [0.58, 0.68] 
 BL-FU 20.33 <.01 0.62 [0.56, 0.68] 18.86 <.01 0.58 [0.52, 0.64] 
 Post-FU -0.10 =.92 -0.00 [-0.07, 0.06] 1.81 =.07 0.05 [-0.01, 0.11] 
Note. V-I = Values Importance (Range 1-10); V-A = Valued Action (Range 1-10); VLQ-C = Valued 
Living Questionnaire Composite (Range 10-100); GSI = Global Severity Index (Range 0-4); BDI-II = 
Beck-Depression Inventory – II (Range 0-63); SWLS = Satisfaction with Life Scale (Range 0-25); BL = 
Baseline, Pre-treatment; Post = Post-treatment; FU = Follow-up; ES = Effect size; CI = Confidence 
Interval. Significant p-values are bold. 
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Table 4. Correlations between outcomes at baseline [Back to Results]. 
 VLQ-C GSI BDI-II SWLS 
VLQ-C r (3685) = 1    
p <.001    
GSI r (3665) = -.34 r (5177) = 1   
p <.001 <.001   
BDI-II r (3685) = -.41 r (5177) =.72 r (5353) = 1  
p <.001 <.001 <.001  
SWLS r (3643) =.56 r (4925) = -.48 r (5097) = -.57 r (5100) = 1 
p <.001 <.001 <.001 <.001 
Note. VLQ-C = Valued Living Composite; GSI = Global Severity Index; BDI-II = Beck 
Depression Inventory II; SWLS = Satisfaction with life scale 
24 
 
Table 5. Summary of hierarchical regression analysis for variables predicting satisfaction with life at end of treatment [Back to Results]. 
Predictors Block 1   Block 2   Block 3   
 B SEB β B SEB β B SEB β 
SWLS-BL 0.46 0.03 0.45** 0.46 0.02 0.45** 0.43 0.02 0.42** 
BDI-II-BL -0.08 0.03 -0.11** -0.27 0.03 -0.36** -0.22 0.03 -0.29** 
GSI-BL 0.48 0.40 0.04 -1.64 0.48 -0.14** -1.58 0.46 -0.14** 
VLQ-C-BL 0.27 0.67 0.11** 0.16 0.05 0.07** 0.42 0.05 0.18** 
ΔGSIBL-Post    3.48 0.49 0.30** 2.90 0.47 0.25** 
ΔBDIBL-Post    0.30 0.03 0.40** 0.25 0.03 0.33** 
ΔVLQ-CBL-Post       -0.59 0.05 -0.23** 
ΔR2   -   .269   .037 
R2   .323   .592   .629 
F for ΔR2  F (4, 1262) = 150.54**  F (2, 1260) = 414.82**  F (1, 1259) = 126.88** 
Note. SWLS-BL = Satisfaction with life scale at baseline; BDI-II-BL = Beck Depression Inventory II at baseline; GSI-BL = Global Severity 
Index at baseline; VLQ-C-BL = Valued Living Composite at baseline; ΔGSIBL-Post = Change in Global Severity Index from baseline to post-
treatment; ΔBDIBL-Post = Change in Beck Depression Inventory II from baseline to post-treatment. All predictors were mean-centered. 
Significant predictors in each block are bold. 
* p < .05, ** p < .01 
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Table 6. Summary of hierarchical regression analysis for variables predicting the change in Global Severity Index and in the Beck Depression 
Inventory II from post-treatment to follow-up [Back to Results] 
 ΔGSIPost-FU ΔBDIPost-FU 
Predictors Block 1   Block 2   Block 1   Block 2   
 B SEB β B SEB β B SEB β B SEB β 
GSI-BL -0.04 0.03 -0.07 -0.03 0.03 -0.07 -0.77 0.55 -0.08 -0.74 0.55 -0.08 
BDI-II-BL 0.00 0.00 0.09 0.00 0.00 0.08 0.00 0.04 0.00 -0.00 0.04 -0.01 
VLQ-C-BL 0.01 0.01 0.09* 0.01 0.01 0.05 0.06 0.08 0.03 -0.00 0.09 -0.00 
ΔVLQ-CBL-Post    0.01 0.01 0.10*    0.17 0.08 0.09* 
ΔR2   -   .008   -   .006 
R2   .010   .018   .010   .016 
F for ΔR2  F (3, 604) = 1.97  F (1, 603) = 4.93*  F (3, 604) = 1.96  F (1, 603) = 3.95* 
Note. ΔGSIPost-FU = Change in Global Severity Index from post-treatment to follow-up; ΔBDIPost-FU = Change in Beck Depression Inventory II 
from post-treatment to follow-up; GSI-BL = Global Severity Index at baseline; BDI-II-BL = Beck Depression Inventory II at baseline; VLQ-
C-BL = Valued Living Composite at baseline; ΔVLQ-CBL-Post = Change in Valued Living Composite from baseline to post-treatment. All 
predictors are mean-centered. Significant predictors in each block are bold. 
* p < .05, ** p < .01 
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Figures 
 
Figure 1. Mean importance, action/consistency and discrepancy of individual values. [Back to Results]. 
Work
Recreation/
Fun
Education/
Training
Marriage/
Couples/
Intimate
relationships
Parenting
Friends/Social
life
Family Spirituality
Physical self
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Importance 4.02 4.19 3.88 4.49 4.05 4.42 4.47 2.51 4.48 3.06
Action 2.72 2.89 2.99 2.91 2.8 3.31 3.32 2.36 2.75 2.47
Discrepancy 1.3 1.3 0.89 1.6 1.26 1.11 1.15 0.15 1.72 0.6
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